AGEN - Agenus Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Lexington,
United States
Type: Equity
AGEN price evolution
AGEN
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $76.11 | $106.31 | $143.21 | $164.82 |
| Short term investments | $14.65 | $24.41 | ||
| Net receivables | $25.84 | $1.03 | $1.34 | $1.42 |
| Inventory | ||||
| Total current assets | $112.42 | $125.55 | $170.74 | $205.69 |
| Long term investments | ||||
| Property, plant & equipment | $163.03 | $169.7 | $173.89 | $171.46 |
| Goodwill & intangible assets | $29.13 | $29.16 | $29.71 | $31.28 |
| Total noncurrent assets | $201.5 | $209.92 | $212.86 | $207.16 |
| Total investments | $14.65 | $24.41 | ||
| Total assets | $313.91 | $335.47 | $383.59 | $412.85 |
| Current liabilities | ||||
| Accounts payable | $61.45 | $40.87 | $52.47 | $46.77 |
| Deferred revenue | $1.16 | $6.14 | $8.97 | $11.03 |
| Short long term debt | $2.73 | $2.95 | $2.53 | $2.99 |
| Total current liabilities | $255.9 | $198.36 | $204.07 | $190.9 |
| Long term debt | $75.28 | $75.89 | $74.93 | $75.48 |
| Total noncurrent liabilities | $206.4 | $252.41 | $256.29 | $275.06 |
| Total debt | $78.01 | $78.83 | $77.45 | $78.48 |
| Total liabilities | $462.3 | $450.76 | $460.35 | $465.96 |
| Shareholders' equity | ||||
| Retained earnings | -$1955.67 | -$1909.38 | -$1847.18 | -$1778.16 |
| Other shareholder equity | -$0.95 | -$1.03 | -$0.72 | $0.92 |
| Total shareholder equity | -$160.33 | -$129.11 | -$93.19 | -$58.54 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $76.11 | $178.67 | $291.93 | $99.87 |
| Short term investments | $14.68 | $14.99 | ||
| Net receivables | $25.84 | $2.74 | $1.52 | $1.16 |
| Inventory | ||||
| Total current assets | $112.42 | $213.12 | $331.97 | $113.78 |
| Long term investments | ||||
| Property, plant & equipment | $163.03 | $164.29 | $91.08 | $60.27 |
| Goodwill & intangible assets | $29.13 | $31.7 | $33.36 | $36.34 |
| Total noncurrent assets | $201.5 | $200.43 | $133.98 | $100.73 |
| Total investments | $14.68 | $14.99 | ||
| Total assets | $313.91 | $413.56 | $465.96 | $214.51 |
| Current liabilities | ||||
| Accounts payable | $61.45 | $40.94 | $30.49 | $17.02 |
| Deferred revenue | $1.16 | $13.41 | $23.63 | $45.47 |
| Short long term debt | $2.73 | $2.52 | $3.35 | $2.78 |
| Total current liabilities | $255.9 | $188.95 | $156.94 | $129.88 |
| Long term debt | $75.28 | $24.85 | $54.93 | $52.94 |
| Total noncurrent liabilities | $206.4 | $279.51 | $261.11 | $296.13 |
| Total debt | $78.01 | $78.43 | $58.29 | $55.73 |
| Total liabilities | $462.3 | $474.83 | $418.05 | $426.01 |
| Shareholders' equity | ||||
| Retained earnings | -$1955.67 | -$1709.91 | -$1489.83 | -$1465.91 |
| Other shareholder equity | -$0.95 | $0.92 | $1.49 | $2.77 |
| Total shareholder equity | -$160.33 | -$61.28 | $34.44 | -$203.67 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $83.8 | $25.3 | ||
| Cost of revenue | $0.26 | $0.25 | ||
| Gross Profit | $83.54 | $25.04 | ||
| Operating activities | ||||
| Research & development | $66.72 | $59.28 | ||
| Selling, general & administrative | $21.18 | $20.41 | ||
| Total operating expenses | $87.9 | $79.7 | ||
| Operating income | -$4.36 | -$54.66 | ||
| Income from continuing operations | ||||
| EBIT | -$2.11 | -$50.5 | ||
| Income tax expense | ||||
| Interest expense | $44.18 | $18.52 | ||
| Net income | ||||
| Net income | -$46.29 | -$69.02 | ||
| Income (for common shares) | -$46.34 | -$69.07 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $156.31 | $98.02 | $295.67 | $88.17 |
| Cost of revenue | $3.11 | $10.57 | $3.47 | $2.35 |
| Gross Profit | $153.2 | $87.46 | $292.19 | $85.82 |
| Operating activities | ||||
| Research & development | $234.57 | $186.69 | $178.61 | $142.62 |
| Selling, general & administrative | $78.74 | $81.01 | $76.36 | $59.22 |
| Total operating expenses | $313.31 | $267.7 | $254.97 | $201.84 |
| Operating income | -$160.1 | -$180.24 | $37.23 | -$116.01 |
| Income from continuing operations | ||||
| EBIT | -$147.84 | -$158.21 | $41.79 | -$119.84 |
| Income tax expense | ||||
| Interest expense | $97.92 | $61.86 | $65.72 | $61.08 |
| Net income | ||||
| Net income | -$245.76 | -$220.07 | -$23.93 | -$180.91 |
| Income (for common shares) | -$245.97 | -$220.29 | -$24.14 | -$181.12 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$46.29 | -$62.2 | -$69.02 | -$68.25 |
| Operating activities | ||||
| Depreciation | $5.2 | $2.85 | $2.97 | $2.56 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.46 | $5.88 | $6.04 | $5.49 |
| Total cash flows from operations | -$40.4 | -$65.23 | -$60.04 | -$58.53 |
| Investing activities | ||||
| Capital expenditures | $2.79 | -$3.45 | -$4.09 | -$1.84 |
| Investments | $0.03 | $15 | $4.6 | -$9.65 |
| Total cash flows from investing | $2.82 | $11.55 | $0.52 | -$11.49 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $9.98 | $20.76 | $40.52 | $58.14 |
| Net borrowings | -$2.62 | -$2.39 | -$2.02 | -$1.89 |
| Total cash flows from financing | $7.32 | $18.04 | $38.26 | $56.25 |
| Effect of exchange rate | $0.07 | -$0.26 | -$0.35 | -$0.09 |
| Change in cash and equivalents | -$30.2 | -$35.9 | -$21.61 | -$13.86 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$245.76 | -$220.07 | -$23.93 | -$180.91 |
| Operating activities | ||||
| Depreciation | $13.59 | $6.95 | $6.79 | $7.18 |
| Business acquisitions & disposals | -$2.92 | -$0.97 | ||
| Stock-based compensation | $22.87 | $18.34 | $19.58 | $10.42 |
| Total cash flows from operations | -$224.2 | -$175.37 | $10.14 | -$139.1 |
| Investing activities | ||||
| Capital expenditures | -$6.59 | -$31.06 | -$28.16 | -$3.47 |
| Investments | $9.99 | $0.37 | -$14.99 | |
| Total cash flows from investing | $3.4 | -$33.61 | -$43.15 | -$4.44 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $129.4 | $96.32 | $205.13 | $180.89 |
| Net borrowings | -$8.93 | -$0.49 | -$1.32 | $2.96 |
| Total cash flows from financing | $119.87 | $95.83 | $225.26 | $183.85 |
| Effect of exchange rate | -$0.63 | -$0.1 | -$0.16 | $0.38 |
| Change in cash and equivalents | -$101.56 | -$113.26 | $192.09 | $40.7 |
News
Fundamentals
| Market cap | $4.78B |
|---|---|
| Enterprise value | $4.78B |
| Shares outstanding | 394.37M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 195.22% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | -29.99 |
| Book/Share | -0.40 |
| Cash/Share | 0.19 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -2.88 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.44 |
| Quick ratio | 0.44 |